AstraZeneca wins U.S. FDA approval for first-line use of lung cancer drug
(Reuters) - AstraZeneca Plc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved the 1st-line use of its lung cancer drug, Tagrisso.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Health | Lung Cancer